Evidence map›Paper›PMID 26317114›Full record

ArticleReceptors & clinical investigation

Vascular protective effects of Angiotensin Receptor Blockers: Beyond Blood pressure.

Sandeep Artham, Abdelrahman Y Fouda, Azza B El-Remessy, Susan C Fagan

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Receptors & clinical investigation. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed.

  1. Article
  2. Pharmacogenomics Informs Cardiovascular Pharmacotherapy.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  3. Article
  4. Within the Brain: The Renin Angiotensin System.International journal of molecular sciences · 2018
    Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Sandeep ArthamProgram in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, and Georgia Regents University, Charlie Norwood VA Medical Center, Augusta, GA, USA.
Abdelrahman Y FoudaProgram in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, and Georgia Regents University, Charlie Norwood VA Medical Center, Augusta, GA, USA.
Azza B El-RemessyProgram in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, and Georgia Regents University, Charlie Norwood VA Medical Center, Augusta, GA, USA.
Susan C FaganProgram in Clinical and Experimental Therapeutics, University of Georgia College of Pharmacy, and Georgia Regents University, Charlie Norwood VA Medical Center, Augusta, GA, USA.

Funding

Molecular Mechanisms of diabetic retinopathyR01EY022408 · NEI · UNIVERSITY OF GEORGIA · PI EL-REMESSY, AZZA B · 2012 to 2016
$1.5M
Mechanisms of Vascular Protection after Acute StrokeR01NS063965 · NINDS · UNIVERSITY OF GEORGIA · PI FAGAN, SUSAN C · 2009 to 2013
$1.4M
Mechanisms and Consequences of Hypertension after StrokeI01BX000891 · VA · CHARLIE NORWOOD VA MEDICAL CENTER · PI FAGAN, SUSAN C · 2011 to 2014
–
BLRD VA I01 BX000891NEI NIH HHS R01 EY022408NINDS NIH HHS R01 NS063965
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

angiogenesisARBcandesartanischemic retinopathystrokevascular protectionVEGF

Identifiers

PMID26317114
PMCPMC4548973

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.